385 related articles for article (PubMed ID: 11073754)
1. Susceptibility testing for mycobacteria.
Woods GL
Clin Infect Dis; 2000 Nov; 31(5):1209-15. PubMed ID: 11073754
[TBL] [Abstract][Full Text] [Related]
2. [Mycobacterial tests].
Takashima T; Higuchi T
Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
[TBL] [Abstract][Full Text] [Related]
3. In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.
Hoel T; Casals JB; Eng J
APMIS; 1993 Jan; 101(1):27-32. PubMed ID: 8457323
[TBL] [Abstract][Full Text] [Related]
4. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility.
Uslan DZ; Kowalski TJ; Wengenack NL; Virk A; Wilson JW
Arch Dermatol; 2006 Oct; 142(10):1287-92. PubMed ID: 17043183
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility testing of rapidly growing mycobacteria by microdilution - experience of a tertiary care centre.
Set R; Rokade S; Agrawal S; Shastri J
Indian J Med Microbiol; 2010; 28(1):48-50. PubMed ID: 20061764
[TBL] [Abstract][Full Text] [Related]
6. [Multicenter evaluation of a newly developed microdilution test, brothMIC NTM to determine minimum inhibitory concentrations of antimicrobial agents for nontuberculous mycobacteria].
Yamane N; Onaga S; Saitoh H; Toyoshima S; Shimojima M; Kawahara S; Takashima T; Yamashita T
Rinsho Byori; 2002 Apr; 50(4):381-91. PubMed ID: 12014018
[TBL] [Abstract][Full Text] [Related]
7. [Standardization of laboratory tests for tuberculosis and their proficiency testing].
Abe C
Kekkaku; 2003 Aug; 78(8):541-51. PubMed ID: 14509226
[TBL] [Abstract][Full Text] [Related]
8. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
9. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
Akselband Y; Cabral C; Shapiro DS; McGrath P
J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
[TBL] [Abstract][Full Text] [Related]
10. [In vitro study of the susceptibility of mycobacteria to sulfonamides by the disc and percentage methods (author's transl)].
Demoulin L; Médard M; Kellens J
Pathol Biol (Paris); 1982 Apr; 30(4):201-5. PubMed ID: 7045778
[TBL] [Abstract][Full Text] [Related]
11. [Susceptibility to antimicrobial agents of rapidly growing mycobacteria].
Ruiz-Aragón J; García-Agudo L; Flores S; Rodríguez MJ; Marín P; García-Martos P
Rev Esp Quimioter; 2007 Dec; 20(4):429-32. PubMed ID: 18563216
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI
Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
[TBL] [Abstract][Full Text] [Related]
13. In vitro drug susceptibility of Mycobacterium other than tubercle bacilli.
Imwidthaya P; Komolpis P; Suthiravitayavaniz K; Rienthong S
J Med Assoc Thai; 1990 Aug; 73(8):438-42. PubMed ID: 2262746
[TBL] [Abstract][Full Text] [Related]
14. [In vitro susceptibility testing of nontuberculous mycobacteria to streptomycin, kanamycin and enviomycin].
Tsukamura M
Kekkaku; 1989 Sep; 64(9):557-62. PubMed ID: 2554046
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae.
Aono A; Morimoto K; Chikamatsu K; Yamada H; Igarashi Y; Murase Y; Takaki A; Mitarai S
J Infect Chemother; 2019 Feb; 25(2):117-123. PubMed ID: 30447882
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results].
Tsukamura M; Yamori S
Kekkaku; 1990 May; 65(5):349-57. PubMed ID: 2168003
[TBL] [Abstract][Full Text] [Related]
17. Clinical mycobacteriology. Drug susceptibility testing.
Heifets LB
Clin Lab Med; 1996 Sep; 16(3):641-56. PubMed ID: 8866184
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria.
Vera-Cabrera L; Brown-Elliott BA; Wallace RJ; Ocampo-Candiani J; Welsh O; Choi SH; Molina-Torres CA
Antimicrob Agents Chemother; 2006 Dec; 50(12):4027-9. PubMed ID: 17015632
[TBL] [Abstract][Full Text] [Related]
19. [Sulfadimethoxine as a promising drug in the treatment of infections caused by Mycobacterium kansasii and Mycobacterium xenopi--differentiation between M. kansasii and M. marinum and between M. gordonae and M. scrofulaceum by the susceptibility testing to sulfadimethoxine].
Tsukamura M
Kekkaku; 1989 Apr; 64(4):313-7. PubMed ID: 2747117
[TBL] [Abstract][Full Text] [Related]
20. Drug susceptibility testing of nontuberculous mycobacteria.
van Ingen J; Kuijper EJ
Future Microbiol; 2014; 9(9):1095-110. PubMed ID: 25340838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
